Karpa Kelly Dowhower, Lewis Peter R, Felix Todd Matthew
Department of Pharmacology at Penn State Milton S Hershey Medical Center, 500 University Drive R130, Hershey, PA 17033.
Department of Family and Community Medicine at Penn State Milton S Hershey Medical Center, 500 University Drive H154, Hershey, PA 17033.
FP Essent. 2015 Sep;436:11-6.
Adverse drug reactions (ADRs) contribute to substantial morbidity and mortality and add to rising health care costs. Many ADRs are preventable with appropriate prescribing and monitoring because they often occur as an extension of a drug's mechanism of action or known drug interactions. Patients at higher risk of ADRs include those at the extremes of age, those with multiple comorbidities, those taking multiple drugs, and patients admitted to intensive care units or experiencing transitions of care. Because the risk of ADRs becomes greater as the number of drugs and dietary supplements taken increases, it is imperative that prescribers be vigilant about the prescribing cascade and take steps to discontinue drugs that are likely to be more harmful than helpful. Pharmacists serve as important partners in clinical care environments by conducting comprehensive drug reviews, aiding in drug/dosage selection, and developing therapeutic monitoring plans. Although the potential exists for clinicians to use electronic health record systems to aid in clinical decision making through drug safety decision support tools, computer systems should never replace clinical judgment. Clinicians also are encouraged to report ADRs to the Food and Drug Administration Adverse Event Reporting System.
药物不良反应(ADR)会导致大量发病和死亡,并使医疗费用不断攀升。许多ADR通过适当的处方和监测是可以预防的,因为它们常常作为药物作用机制或已知药物相互作用的延伸而发生。ADR风险较高的患者包括年龄极大或极小者、患有多种合并症者、服用多种药物者以及入住重症监护病房或经历护理转接的患者。由于服用的药物和膳食补充剂数量增加时ADR风险会变得更高,因此开处方者必须警惕处方级联反应,并采取措施停用可能弊大于利的药物。药剂师通过进行全面的药物审查、协助药物/剂量选择以及制定治疗监测计划,在临床护理环境中充当重要合作伙伴。尽管临床医生有可能利用电子健康记录系统,通过药物安全决策支持工具辅助临床决策,但计算机系统绝不能取代临床判断。还鼓励临床医生向美国食品药品监督管理局不良事件报告系统报告ADR。